Compare Merck & Co., Inc. (MRK) vs Unity Software Inc (U) Price & Performance

Merck & Co., Inc.Trade

Unity Software IncTrade

Price performance (Past 24H)

Key statistics

Merck & Co., Inc. vs Unity Software Inc — how do they compare? Merck & Co., Inc. trades at $130.04 (market cap $321.77B), while Unity Software Inc trades at $43.45 (market cap $19.31B). The key difference: Merck & Co., Inc. is far larger — about 16.7× Unity Software Inc's market cap, and Merck & Co., Inc. pays a 2.61% dividend while Unity Software Inc pays none. Which is the better fit depends on your goals.

	MRK	U
Market Cap	$321.77B	$19.31B
Sector	Health	Technology
52-Week High	$131.84	$49.47
52-Week Low	$77.60	$17.13
Enterprise Value	$368.53B	$19.19B
Dividend Yield	2.61%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Merck & Co., Inc.

Merck (MRK) trades at $130.90, up 1.81% on the day, with a bullish technical outlook and strong institutional support. Recent earnings beats in Q4 2025 and Q1-Q2 2026, alongside a 28.07% net income margin in 2025, highlight operational strength. The acquisition of Terns Pharmaceuticals aims to bolster its oncology pipeline, though a high P/E of 104.74 signals premium valuation. Cash flow remains positive at $1.37B in 2025, but investing outflows have increased.

The stock offers growth potential from pipeline expansion and analyst consensus targeting $140.36, but risks include elevated debt-to-asset ratios (36.06% in 2025) and competitive pressures. Investors should weigh robust profitability against valuation concerns and macroeconomic headwinds affecting the pharma sector.

Unity Software Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRK

Bio-Techne reports flat FY2026 revenue, EPS rise, and confirms $11.3B acquisition by Merck KGaA.PRNewsWire · 4 hours agoBullish Trump orders splitting MMR vaccine into three shots despite no scientific support and expert criticism.CNBC · 22 hours agoBearish View details →

Unity shares rise as analysts boost price targets on strong Vector platform growthProactive Investors · 4 days agoBullish Unity Software stock jumps after strong Q2 earnings and higher price target from Wells Fargo.Andrew Wynn · 4 days agoBullish View details →

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

About Unity Software Inc

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.